• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Immunocytochemically demonstrated expression of epithelial membrane antigen and carcinoembryonic antigen by exfoliated urinary cells in patients with bladder cancer.

作者信息

Tanaka K, Takashi M, Miyake K, Koshikawa T

机构信息

Department of Urology, Nagoya University School of Medicine, Japan.

出版信息

Urol Int. 1994;52(3):140-4. doi: 10.1159/000282593.

DOI:10.1159/000282593
PMID:8203052
Abstract

The localization of epithelial membrane antigen (EMA) and carcinoembryonic antigen (CEA) in exfoliated cells from voided urine was examined to clarify whether immunostaining for these markers is more useful than conventional cytology for diagnosis of patients with transitional cell carcinoma of the bladder. Both EMA and CEA were present more frequently in specimens from higher-grade and higher-stage tumors than lower-grade and lower-stage tumors. Cells positive for one or both of these markers were also found in specimens from cancer patients with only suspicious results by conventional cytology. In grade 1 tumors, the positive rates were 50% for EMA staining and 40% for CEA staining compared with 10% for conventional cytology. In 12 patients with cystitis, results for EMA staining and conventional cytology were all negative, whereas CEA staining proved positive in 6 patients (50%). None of 10 normal subjects with conventional cytology had positive results for EMA or CEA staining. These findings indicate that immunocytochemistry for EMA is a more useful adjunctive method than CEA staining or conventional cytology for detection of tumor cells, especially in cases of low-grade bladder cancer.

摘要

相似文献

1
Immunocytochemically demonstrated expression of epithelial membrane antigen and carcinoembryonic antigen by exfoliated urinary cells in patients with bladder cancer.
Urol Int. 1994;52(3):140-4. doi: 10.1159/000282593.
2
[Immunohistochemical localization of epithelial membrane antigen, carcinoembryonic antigen and secretory component in urinary bladder cancer].[上皮膜抗原、癌胚抗原和分泌成分在膀胱癌中的免疫组织化学定位]
Hinyokika Kiyo. 1986 Apr;32(4):541-52.
3
Behavior of epithelial differentiation antigens (carcinoembryonic antigen, epithelial membrane antigen, keratin and cytokeratin) in transitional cell carcinomas of the bladder.膀胱移行细胞癌中上皮分化抗原(癌胚抗原、上皮膜抗原、角蛋白和细胞角蛋白)的表现
Urol Int. 1992;48(1):14-9. doi: 10.1159/000282289.
4
[Clinicopathological study of urinary bladder tumors. Clinical evaluation of immunohistochemistry in urine cytology].膀胱肿瘤的临床病理研究。尿液细胞学免疫组织化学的临床评估
Hinyokika Kiyo. 1985 Nov;31(11):1931-7.
5
Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.核基质蛋白、纤连蛋白、膀胱癌抗原及晨尿细胞学检查在膀胱肿瘤检测中的比较评估
J Urol. 2002 Aug;168(2):465-9.
6
Enhanced detection of bladder cancer using the epithelial surface marker epithelial membrane antigen: a preliminary report.利用上皮表面标志物上皮膜抗原增强膀胱癌检测:初步报告
J Occup Med. 1990 Sep;32(9):904-9. doi: 10.1097/00043764-199009000-00030.
7
Immunocytochemical analysis of prostate stem cell antigen as adjunct marker for detection of urothelial transitional cell carcinoma in voided urine specimens.前列腺干细胞抗原的免疫细胞化学分析作为检测排尿标本中尿路上皮移行细胞癌的辅助标志物。
J Urol. 2003 Jun;169(6):2094-100. doi: 10.1097/01.ju.0000064929.43602.17.
8
Evaluation of urinary level of NMP22 as a diagnostic marker for stage pTa-pT1 bladder cancer: comparison with urinary cytology and BTA test.评估尿NMP22水平作为pTa-pT1期膀胱癌诊断标志物的价值:与尿细胞学检查及BTA检测的比较
Eur Urol. 1999 Feb;35(2):93-7. doi: 10.1159/000019825.
9
[Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].[尿BTA-TRAK在浅表性移行细胞膀胱癌随访中的应用]
Arch Esp Urol. 2002 Jan-Feb;55(1):41-9.
10
Enhanced expression of a tumor-cell-derived collagenase-stimulatory factor in urothelial carcinoma: its usefulness as a tumor marker for bladder cancers.
Int J Cancer. 1993 Aug 19;55(1):19-26. doi: 10.1002/ijc.2910550105.

引用本文的文献

1
Expression of E-cadherin, β-catenin, and epithelial membrane antigen does not predict survival in patients with high-risk non-muscle-invasive bladder cancer.E-钙黏蛋白、β-连环蛋白和上皮膜抗原的表达不能预测高危非肌肉浸润性膀胱癌患者的生存率。
Cent Eur J Immunol. 2018;43(4):421-427. doi: 10.5114/ceji.2018.79509. Epub 2018 Dec 31.
2
Bladder tumor markers: need, nature and application. 2. Tumor and tumor-associated antigens.膀胱肿瘤标志物:需求、性质与应用。2. 肿瘤及肿瘤相关抗原。
Int Urogynecol J Pelvic Floor Dysfunct. 1998;9(4):228-35. doi: 10.1007/BF01901609.